Adult urologyHuman glandular kallikrein 2 (hK2) expression in prostatic intraepithelial neoplasia and adenocarcinoma: A novel prostate cancer marker
References (21)
- et al.
Molecular forms of prostate-specific antigen and the human kallikrein gene family: a new era
Urology
(1995) - et al.
Prostate-specific antigen: critical issues for the practicing physician
Mayo Clin Proc
(1994) - et al.
High level of expression in the prostate of a human glandular kallikrein mRNA related to prostate-specific antigen
FEBS Lett
(1988) - et al.
Prostate-specific antigen and prostatic acid phosphatase immunoreactivity as prognostic indicators of advanced prostatic carcinoma
J Urol
(1993) - et al.
Dual monoclonal antibody immunoassay for free prostate-specific antigen
Prostate
(1996) - et al.
Evaluation of percentage of free serum prostate-specific antigen to improve specificity of prostate cancer screening
JAMA
(1995) - et al.
Characterization and evaluation of hK2: a potential prostate cancer marker, closely related to PSA
- et al.
Detection of a prostate-specific protein, human glandular kallikrein 2 (hK2), in sera of patients with elevated prostate specific antigen levels
Urology
(1997) Structure, function and regulation of the enzyme activity of prostate-specific antigen
World J Urol
(1993)- et al.
Tissue-specific and hormonal regulation of human prostate-specific glandular kallikrein
Biochemistry
(1992)
There are more references available in the full text version of this article.
Cited by (202)
miRNAs as Molecular Biomarkers for Prostate Cancer
2022, Journal of Molecular DiagnosticsNovel Agents and Future Perspectives on Theranostics
2021, Seminars in Radiation OncologyCitation Excerpt :hK2 is largely expressed in normal prostate with higher expression in prostate cancer and negligible expression in other normal tissues. It is driven by androgen receptor signaling identical to prostate specific antigen (PSA)43 but the circulating levels of hK2 are very low and hK2 independently improved discrimination of severity of disease by 2%.44 The expression of hK2 is highly specific for prostate adenocarcinoma and increases with disease progression, hK2-targeted therapies seem attractive.
Serine proteases leading to prostate cancer: Structures, functions, and development of anticancer drugs
2020, Cancer-Leading Proteases: Structures, Functions, and InhibitionNeoplasms of the Prostate
2020, Urologic Surgical PathologyNonneoplastic Diseases of the Prostate
2020, Urologic Surgical Pathology
Copyright © 1997 Published by Elsevier Inc.